Summary of the effect of MPDD on SDLP across all participants, and also participants categorized by driving styles (“NS” (no significant), “+” (significant increase), and “-” (significant decrease)). by Mobina Faqani (22783963)

“…<p>Summary of the effect of MPDD on SDLP across all participants, and also participants categorized by driving styles (“NS” (no significant), “+” (significant increase), and “-” (significant decrease)).…”

Summary of the effect of MPDD on ART and TIBL across all participants, and also participants categorized by driving styles (“NS” (no significant), “+” (significant increase), and “-” (significant decrease). by Mobina Faqani (22783963)

“…<p>Summary of the effect of MPDD on ART and TIBL across all participants, and also participants categorized by driving styles (“NS” (no significant), “+” (significant increase), and “-” (significant decrease).…”

Optogenetic stimulation of the hippocampal CA1 astrocytes does not significantly affect the expression of AMPA receptors or VGLUT2. by Jae-Hong Kim (124622)

LCN2 treatment does not significantly alter the membrane expression of AMPA receptors or VGLUT2 in the hippocampal neurons. by Jae-Hong Kim (124622)

NN analysis to assign the importance of variables. by Sulmaz Ghahramani (3387635)

Positional cloning of <i>qNN1</i> on chromosome 16. by Xinxin Li (281237)

<i>GmNN1/FT2a</i> expression analysis. by Xinxin Li (281237)

Demographic and clinical characteristics of cognitive decliners versus non-decliners (Mean [SD]). by Yishai Levin (702481)

Subjects:

Comparative analysis of macronutrient compositions between baseline and end of intervention (*p < 0.05, ^ns Non-significant results). by Duc Tran Quang (20564967)

Comparative analysis of caloric intake between baseline and end of intervention (*p < 0.05, ^ns Non-significant results). by Duc Tran Quang (20564967)

Box plots and plots of predicted values versus time, with prediction confidence intervals based on the glycopeptiform intensities for the two significant glycopeptiforms of haptoglobin, that were significantly altered both at time point 1 and in the rate of change when comparing cognitive decliners versus non-decliners. by Yishai Levin (702481)

Subjects:

Mean values and 95% confidence intervals for recovery time, Average NN Interval (AVNN); Standard Deviation of NN Intervals (SDNN), Low Frequency/ High Frequency Ratio (LF/HF); and... by Robert Trybulski (10998702)

Volcano plots comparing the relative intensities of glycopeptiforms measured in serum samples from cognitive decliners versus non-decliners at time point 1 (A); and (B) the differe... by Yishai Levin (702481)

Subjects:

Summary of factors significantly associated with worse or better cognitive performance and/or faster or slower cognitive decline^a. by Darren M. Lipnicki (331901)

Declining reference experimental data. by Giovanny Marquez (18554543)

Pathway analysis based on the protein accessions from the significant glycopeptiforms separately for glycation and glycosylation. by Yishai Levin (702481)

Subjects:

Clinical and laboratory measurements of patients with ALS (N = 13; Mean±SD; ns = not significant; nd = not determined; * = evidence of subgroup responsiveness). by Ann Logan (9361)

Venn diagram describing the number of glycopetiforms significantly related with baseline cognitive status and with rate of cognitive decline over time. by Yishai Levin (702481)

Subjects:

Classification accuracy for different modalities and the multi-modal analysis based on significant components of each modality. by Mohammad Javad Sedghizadeh (9772591)

Table_2_Prognostic significance of β2-microglobulin decline index in multiple myeloma.docx by Tianyu Zhang (188439)

“…Purpose<p>To assess the prognostic significance of β2-microglobulin decline index (β2M DI) in multiple myeloma (MM).…”